World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00469261
Date of registration: 03/05/2007
Primary sponsor: Careggi Hospital
Public title: Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling TIPTOP
Scientific title: Tetracycline (Doxycycline) In Patients With Large Acute Myocardial Infarction TO Prevent Left Ventricular Remodeling. TIPTOP Study
Date of first enrolment: May 2007
Target sample size: 110
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00469261
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Italy
Contacts
Name:   Renato Valenti, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital , Florence, Italy
Name:   Alberto Santini, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   David Antoniucci, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Emilio V Dovellini, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Giampaolo Cerisano, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Nazario Carrabba, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Paolo D Pucci, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Piergiovanni Buonamici, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Name:   Umberto Signorini, MD
Address: 
Telephone:
Email:
Affiliation:  Careggi Hospital, Florence, Italy
Key inclusion & exclusion criteria

Inclusion Criteria:

- Acute myocardial infarction

- Left ventricular ejection fraction less than 40%

Exclusion Criteria:

- No written consensus

- Allergy to tetracycline

- Mechanical complication of AMI

- Previous myocardial infarction

- Valvular and/or myocardiopathy known or suspected

- Renal failure (creatinine above 2 mg/dL)

- Connective tissue disease

- Pregnancy



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Left Ventricular Remodeling
Myocardial Infarction
Intervention(s)
Drug: Current medical therapy for AMI
Drug: Doxycycline
Primary Outcome(s)
Reduction of LV dilation (six months versus baseline LV end-diastolic volume index by 2D-echocardiogram [echo]) more than 50% in the treated group in comparison to the placebo group [Time Frame: 6 months]
Secondary Outcome(s)
Evaluation of the time course of MMPs and their inhibitors in relation to left ventricular remodeling [Time Frame: 6 months]
Secondary ID(s)
TIP-TOP
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history